RNA, U6 small nuclear 1201, pseudogene (RNU6-1201P)

RNU6-1201P (RNA, U6 small nuclear 1201, pseudogene) refers to a processed pseudogene that originates from the U6 small nuclear RNA (U6 snRNA) gene. The parent U6 snRNA is an essential, highly conserved noncoding RNA component of the spliceosome—the complex responsible for excising introns from pre-mRNA during splicing[1][3]. Pseudogenes such as RNU6-1201P are retrotransposed, nonfunctional genomic copies that may result from LINE-1 (L1)–mediated retrotransposition, often characterized by scattered base mismatches and sometimes poly(A) tails and target site duplications[2]. While U6 snRNA pseudogenes serve as proxies for retrotransposition dynamics and genomic evolution, they do not encode proteins, nor do they directly participate in molecular or disease processes, nor are they current therapeutic targets[2][3]. The U6 snRNA gene is functional and fundamental to RNA splicing, but its pseudogenes, such as RNU6-1201P, are evolutionary relics with no known physiological or pharmacological function[2][3]. Pseudogenes can sometimes participate in regulatory processes (as "competitive endogenous RNAs" in other contexts), but specific evidence for RNU6-1201P having such a function is lacking. RNU6-1201P is best regarded as a genomic marker or artifact rather than a druggable target.

Other names

RNU6-1201PU6 small nuclear RNA 1201 pseudogeneU6 snRNA pseudogeneU6 snRNA-derived processed pseudogene

None. No drugs are directed at this pseudogene; any mechanism would be indirect or irrelevant.